At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.
News|Articles|November 22, 2023
Choosing the Right Temperature Monitoring Solution
Author(s)SpotSee
Data loggers, data monitors and temperature indicators are three reliable solutions for determining what has occurred during shipping and handling of pharmaceuticals. Deciding which temperature monitoring solution will work best for your operation depends upon the product, its value, delivery method and stage in the supply chain. Discover which solution is right for you in our white paper.
Advertisement
Advertisement
Related to this article
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.
PhRMA's lawsuit argues CMS overstepped its demonstration authority by tying Medicare Part B rebates to international prices.
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.
Swisslog's Mark Beers discusses how software helps pharma supply chains adapt to shifting portfolios, strengthen inventory verification and build trust.
At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: PhRMA Sues to Block GLOBE Model and Bayer's $2.2B Ohio Site
2
Why PhRMA Sued to Block Medicare's GLOBE Pricing Model
3
LogiPharma USA 2026: Data Readiness Must Come Before AI
4
Supply Chain Visibility Needs Context Before AI, Says PAXAFE’s Mark Talens
5